Marlon Hinner is Director Immuno-oncology at Pieris Pharmaceuticals. He joined the company in 2011 and led the protein engineering department as well as a bispecific autoimmunity program before taking on his current role. During his PhD and postdoctoral studies, he had worked in different areas of chemical biology and protein engineering at the Max-Planck-Institute of Biochemistry, University of Groningen and Ecole Polytechnique Federale de Lausanne, with a particular focus on investigating molecular mechanisms also by biophysical simulations.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)